Comparative evaluation of international and population-specific risk prediction models for type 2 diabetes: evidence from the kharameh cohort of the PERSIAN study
Open Access
- 3 July 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Various models have been developed for predicting the risk of type 2 diabetes. This study was designed to compare the performance of international and population-specific models in an Iranian population. This cross-sectional analysis examined data from 10,663 participants aged 40-70 years from the Kharameh cohort. The performance of five type 2 diabetes risk prediction models-FINDRISC, ADA, AUSDRISK, the American risk score, and a new logistic regression model was compared using statistical metrics (sensitivity, specificity, AUC) and Decision Curve Analysis to assess clinical utility. As glucose metabolism status worsened from normal to diabetes, mean age, body mass index, waist circumference, and blood pressure increased significantly. The American model showed the highest discriminative ability (AUC = 0.79) and provided the greatest standardized net benefit. The FINDRISC model showed acceptable performance (AUC = 0.72). The ADA and AUSDRISK models performed weaker (AUC = 0.64 and 0.68, respectively). The new logistic model, with an AUC of 0.71, demonstrated high sensitivity (0.82) but low specificity (0.52), making it primarily suitable for high-sensitivity initial screening. The American risk score was the most effective tool, while the lab-free FINDRISC model served as a practical alternative for primary care screening at lower risk thresholds.Keywords
This publication has 28 references indexed in Scilit:
- Protein tyrosine phosphatase 1B protein macromolecule combined with aerobic exercise intervention on lipid metabolism in type II diabetes patientsArchives of Physiology and Biochemistry, 2026
- Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidanceThe Lancet Digital Health, 2025
- Validation of the Finnish Diabetes Risk Score (FINDRISC) in a Central‐European Population for the Prediction of Cumulative Incidence of Type 2 Diabetes Over 8‐Years—Follow‐Up of the Budakalász Health Examination Survey (BHES)Diabetes/Metabolism Research and Reviews, 2025
- Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracyDiabetes Research and Clinical Practice, 2025
- Generalised decision curve analysis for explicit comparison of treatment effectsJournal of Evaluation in Clinical Practice, 2023
- 22-year trends in dysglycemia and body mass index: A population-based cohort study in Savitaipale, FinlandPrimary Care Diabetes, 2021
- Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-studyDiabetes Research and Clinical Practice, 2019
- The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysisInflammation Research, 2019
- Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and DesignAmerican Journal of Epidemiology, 2017
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureThe Lancet, 2014